Dietary supplementation with omega-3 polyunsaturated fatty acids modulate matrix metalloproteinase immunoreactivity in a mouse model of pre-abdominal aortic aneurysm

Heart Lung and Circulation

Volumn 24, Issue 4, 2015, Pages 377-385

  Kavazos, Kristyn ^a   Nataatmadja, Maria ^b   Wales, Kathryn M ^a   Hartland, Elke ^a   Williams, Chloe ^a   Russell, Fraser D ^a  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Abdominal aortic aneurysm; Cytokines; Elastin; Long chain omega 3 polyunsaturated fatty acids; Matrix metalloproteinases; Transforming growth factor 1

Indexed keywords

ANGIOTENSIN II; ELASTIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; OMEGA 3 FATTY ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; APOLIPOPROTEIN E; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; FAT INTAKE; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ELASTIN; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84925043169     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.11.005     Document Type: Article

References (27)

1. Nordon I.M., Hinchliffe J., Loftus I.M., Thompson M.M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011, 8:92-102.
2. Grootenboer N., Bosch J.L., Hendriks J.M., van Sambeek M.R.H.M. Epidemiology, aetiology, risk of rupture and treatment of abdominal aortic aneurysms: Does sex matter?. Eur J Vasc Endovasc Surg. 2009, 38:278-284.
3. Tong J., Cohnert T., Regitnig P., Kohlbacher J., Birner-Gruenberger R., Schriefl A.J., et al. Variations of dissection properties and mass fractions with thrombus age in human abdominal aortic aneurysms. J Biomech. 2014, 47:14-23.
4. Trollope A., Moxon J.V., Moran C.S., Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol. 2011, 20:114-123.
5. Golledge J., Norman P.E. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011, 217:57-63.
6. Epstein D., Sculpher M.J., Powell J.T., Thompson S.G., Brown L.C., Greenhalgh R.M. Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials. Brit J Surg. 2014, 101:623-631.
7. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodelling and vascular disease. Biochem Pharmacol. 2008, 75:346-359.
8. Wilson W.R.W., Anderton M., Schwalbe E.C., Jones J.L., Furness P.N., Bell P.R.F., et al. Matrix metalloproteinase-8 and-9 are increased at the site of abdominal aortic aneurysm rupture. Circulation. 2006, 113:438-445.
9. Eskandari M.K., Vijungco J.D., Flores A., Borensztajn J., Shively V., Pearce W.H. Enhanced abdominal aortic aneurysm in TIMP-1 deficient mice. J Surg Res. 2005, 123:289-293.
10. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000, 105:1641-1649.
11. Yang C.-Q., Li W., Li S.-Q., Li J., Li Y.-W., Kong S.-X., et al. MCP-1 stimulates MMP-9 expression via ERK1/2 and p38 MAPK signaling pathways in human aortic smooth muscle cells. Cell Physiol Biochem. 2014, 34:266-276.
12. Wang Y., Ait-Oufella H., Herbin O., Bonnin P., Ramkhelawon B., Taleb S., et al. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010, 120:422-432.
13. Johnston W.F., Salmon M., Su G., Lu G., Stone M.L., Zhao Y., et al. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2013, 33:294-304.
14. Adkins Y., Kelley D.S. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010, 21:781-792.
15. Wang J.H., Eguchi K., Matsumoto S., Fujiu K., Komuro I., Nagai R., et al. The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodelling. PLOS ONE. 2014, 9:e96286.
16. Cao R.Y., Amand T.S., Ford M.D., Piomelli U., Funk C.D. The murine angiotensin II-induced abdominal aortic aneurysm model: Rupture risk and inflammatory progression patterns. Front Pharmacol. 2010, 1:1-7.
17. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003, 23:1621-1626.
18. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: Clinical mechanistic perspectives. Atherosclerosis. 2008, 197:12-24.
19. Massaro M., Scoditti E., Carluccio M.A., De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids. 2008, 79:109-115.
20. Lee A.H., Hiramatsu N. Role of n-3 series polyunsaturated fatty acids in cardiovascular disease prevention. Nutr Diet Suppl. 2011, 3:93-100.
21. Kurihara T., Shimizu-Hirota R., Shimoda M., Adachi T., Shimizu H., Weiss S.J., et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation 2012, 126:3070-3080.
22. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002, 110:625-632.
23. Neubronner J., Schuchardt J.P., Kressel G., Merkel M., von Schacky C., Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr. 2011, 65:247-254.
24. Russell F.D., Bürgin-Maunder C.S. Distinguishing health benefits of eicosapentaenoic acid and docosahexaenoic acids. Mar Drugs. 2012, 10:2535-2559.
25. Chen X., Lu H., Rateri D.L., Cassis L.A., Daugherty A. Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. Curr Opin Pharmacol. 2013, 13:180-185.
26. Klink A., Heynens J., Herranz B., Lobatto M.E., Arias T., Sanders H.M.H.F., et al. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular MRI. J Am Coll Cardiol. 2011, 58:2522-2530.
27. Cao J., Schwichtenberg K.A., Hanson N.Q., Tsai M.Y. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem. 2006, 52:2265-2272.